Showing results (1-10 of 263) with videos related to
Sort By:
Pageof 27
Acta Pharmaceutica Sinica. B|June 9, 2025
Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and functionYuhong Jiang, Shanshan Qi, Canquan MaoSmall (Weinheim an Der Bergstrasse, Germany)|December 2, 2024
Dual-functional Nanosized Albumin Facilitates CRISPR-Cas9-PAR2 to Mitigate Cytokine Storm via TLR4 and Pyroptosis SignalingJianbin Li, Dongmei Zheng, Shanshan Qi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2025
Manganese oxide nanoparticle acts as a promising immune adjuvant via tuning ferroptosis signalingXiaoyu Liang, Shanshan Qi, Lirong Fang, et al.European Journal of Pharmacology|November 2, 2025
GPCR signaling from endosome: mechanistic insights and therapeutic potentialsLi Chen, Canquan Mao, Yuhong JiangCurrent Pharmaceutical Design|March 6, 2020
G Protein-coupled Receptors in Cancer Stem CellsYuhong Jiang, Xin Zhuo, Canquan MaoACS Nano|November 3, 2023
The Distinct Properties of Polysaccharide Nanoparticles Tune Immune Responses against mRNA Antigen via Stimulator of Interferon Genes-Mediated Autophagy and InflammasomeYue Wu, Xiaoyu Liang, Canquan Mao, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|October 2, 2021
PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expressionYuhong Jiang, Xin Zhuo, Yue Wu, et al.Frontiers in Pharmacology|May 10, 2021
Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR TransactivationYuhong Jiang, Xin Zhuo, Xiujuan Fu, et al.Biochemical Pharmacology|March 27, 2026
Deciphering the immunomodulatory code: how metal nanoadjuvants orchestrate intracellular immune signaling cascadesLirong Fang, Yiting Zhao, Jieling Zhao, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2023
PAR2 deficiency tunes inflammatory microenvironment to magnify STING signalling for mitigating cancer metastasis via anionic CRISPR/Cas9 nanoparticlesXiujuan Fu, Jianbin Li, Yue Wu, et al.Pageof 27